期刊文献+

姜黄素对人肝癌细胞株 He pG2巨噬细胞迁移抑制因子表达的影响

Effect of Curcumin on the Expression of Macrophage Migration Inhibitory Factor in Human Hepatocellular Carcinoma Cell Line HepG2
下载PDF
导出
摘要 [目的]检测人肝癌细胞株HepG2中巨噬细胞迁移抑制因子(MIF)的表达及释放,探讨姜黄素对HepG2中MIF表达的影响。[方法]反转录聚合酶链反应(RT-PCR)及免疫印迹法(Western Blot)检测对照组及不同浓度姜黄素干预组(10,20,30,40,50μmol/L)HepG2中MIF mRNA及蛋白表达水平;ELISA检测对照组及不同浓度姜黄素干预组(10,20,30,40,50μmol/L )培基中 M IF蛋白水平。[结果]HepG2高表达MIF mRNA及MIF蛋白,各浓度姜黄素干预均可抑制HepG2中MIF mRNA及MIF蛋白的表达,且呈浓度依赖效应( P <0.05);HepG2可自分泌MIF蛋白,各浓度姜黄素干预均可抑制 HepG2中MIF 蛋白的释放,且呈浓度依赖效应( P <0.05)。[结论]人肝癌细胞株HepG2可表达及释放MIF ;姜黄素在转录和翻译水平能有效抑制M IF的表达及释放,这可能是其发挥抗肿瘤效应的分子机制之一。 [Objective] To detect the expression and releasing of macrophage migration inhibitory factor (MIF) in human hepatocellular carcinoma cell line HepG2 .and to explore the effect of curcumin on the expres-sion of MIF in HepG2 .[Methods] Reverse transcription polymerase chain reaction (RT-PCR) and Western blotting method were used to detect the expression of MIF mRNA and protein in control group and curcumin treatment groups of different concentrations(10 ,20 ,30 ,40 and 50μmol/L) .The expression of MIF protein in control group and curcumin treatment groups of different concentrations (10 ,20 ,30 ,40 and 50μmol/L) was measured by using ELISA .[Results] The expression of MIF mRNA and protein in HepG2 was high .Curcu-min with different concentrations could inhibit the expression of MIF mRNA and protein in HepG 2 in dose-de-pendent manner( P<0 .05) .MIF protein could be released by HepG2 .Curcumin with different concentrations could inhibit the releasing of MIF protein in HepG2 in dose-dependent manner( P<0 .05) .[Conclusion]MIF is expressed in HepG2 and released by HepG2 .Curcumin can effectively inhibit the expression and releasing of MIF at transcription and translation level ,which may be one of the mechanisms of anti-neoplastic effect of cur-cumin .
出处 《医学临床研究》 CAS 2013年第11期2209-2212,共4页 Journal of Clinical Research
关键词 肝肿瘤 姜黄素 巨噬细胞游走抑制因子 Liver Neoplasms Curcumin Macrophage Migration-Inhibitory Factors
  • 相关文献

参考文献14

  • 1Bulterys M,Goodman MT,Smith MA. Cancer inci-dence and survival among children and adolescents:United States SEER Program 1975-1995.National Cancer Institute SEER Program[J].NIH Publication,1999,(1):46-49.
  • 2Roebuck DJ,Perilongo G. Hepatoblastoma:an oncological review[J].{H}Pediatric Radiology,2006,(3):183-186.
  • 3Trobaugh-Lotrario AD,Katzenstein HM. Chemotherapeutic approaches for newly diagnosed hepatoblastoma:past,pres-ent,and future strategies[J].{H}PEDIATRIC BLOOD & CANCER,2012,(5):809-812.
  • 4Bach JP,Rinn B,Meyer B. Role of MIF in inflamma-tion and tumorigenesis[J].{H}ONCOLOGY-BASEL,2008,(3-4):127-133.
  • 5Bifulco C,McDaniel K,Leng L. Tumor growth-promo-ting properties of macrophage migration inhibitory factor[J].{H}Current Pharmaceutical Design,2008,(36):3790-3801.
  • 6刘娟,游志鹏.姜黄素对糖尿病大鼠视网膜中巨噬细胞游走抑制因子表达的影响[J].眼科研究,2010,28(12):1139-1143. 被引量:8
  • 7Kuttan G,Kumar KB,Guruvayoorappan C. Antitu-mor,antiinvasion,and antimetastatic effects of curcumin[J].{H}Advances in Experimental Medicine and Biology,2007,(1):173-184.
  • 8Nishihira J,Ishibashi T,Fukushima T. Macrophage migration inhibitory factor (MIF):Its potential role in tumor growth and tumor-associated angiogenesis[J].{H}Annals of the New York Academy of Sciences,2003.171-182.
  • 9Mitchell RA,Bucala R. Tumor growth-promoting properties of macrophage migration inhibitory factor (MIF)[J].{H}Seminars in Cancer Biology,2000,(5):359-366.
  • 10Pollard JW. Tumour-educated macrophages promote tumour progression and metastasis[J].{H}Nature Reviews Cancer,2004,(1):71-78.

二级参考文献15

  • 1Adamis AP. ls diabetic retinopathy an inflammatory disease [ J ] ? Br J Ophthahnol,2002,86(4) : 363 - 365.
  • 2Joussen AM, Poulaki V, Le ML, et al. A central role lor inflammation in the pathogenesis of diabetic retinopathy[J].FASEB J,2004,18 (12) : 1450 - 1452.
  • 3Tamura H, Miyamoto K, Kiryu J, et al. Intravitreal injection of corticosteroid attenuates leukostasis and vascular leakage in experimental diabetic retina[J]. Invest Ophthalmol Vis Sci. 2005, 46(4) : 1440 - 1444.
  • 4Banerjee M,Tripathi LM,Srivastava VM,eI al. Modulation of inflammaton medialors by ibuprofen and curcumin treatment during chronic inflammation in rat [J].lmmunopharmac-ul Immunotoxicol, 2003, 25(2): 213 -217.
  • 5中华人民共和困科学技术部关于善待实验动物的指导性意见[S/OL].[2010-03-26].http://www.moslgov.cn/ztkvj/zfwi2006/200512/t2005121454389htm.
  • 6Nishihira J. Macrophage migration inhibitory factor (MIF) :Its essential role in the immune system and cell growth[J]. J Interf Cytok Res, 2000,20(9):751 -762.
  • 7White ES,Flaherty KR,Carskadon S,et al. MIF and CXC chemokinc expression in non-small cell lung cancer: role in angiogenesis anti prognosis[ J ]. Clin Cancer Res,2003,9(2) : 853 - 860.
  • 8Yabunaka N, Nishihira J, Mizue Y, et al. Elevaleted serum content of MIF in patients with type 2 diabetes[J]. Diabet Care, 2002,23(2): 256 - 258.
  • 9Herder C, Klopp N, Baumert J, et al. Effect of maerophage migration inhibitory factor(MlF) gene variants and MIF serum concentrations on the risk of type 2 diabetes:results from the MONICA/KORA Augsburg Case-Cohort Study, 1984 - 2002 [ J]. Diabetoligia, 2008,51 (2) : 276 - 284.
  • 10Yoshinori M, Shinobu T, Akira M, et al. Macrophage migration inhibitory factor level in the vitreous of patients with proliferative diabetic retinopathy [J].Br J Opbthalmol, 2000,84 ( 6 ) : 636 - 639.

共引文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部